Table 4.
Clinical-laboratory characteristics of pure diabetic nephropathic patients.
| Parameters | Diabetic nephropathic patients without non-diabetic renal disease | |||
|---|---|---|---|---|
| Total | Cohorts | Comparisons between cohorts | ||
| With retinopathy | Without retinopathy | |||
| Numbers of patients | 98 | 64 | 34 | p-Value |
| Serum creatinine (uM/L) | 168.52±121.87 | 198.68±149.56 | 182.67±132.56 | 0.548 |
| Albumin (g/L) | 30.78±6.92 | 28.42±7.11 | 32.86±7.01* | 0.033 |
| Hemoglobin (g/L) | 117.52±16.61 | 110.75±16.55 | 115.44±20.33 | 0.301 |
| FPG (mM/L) | 6.98±2.44 | 6.18±2.11 | 6.99±2.86 | 0.060 |
| HbA1C (%) | 6.99±1.08 | 6.89±2.11 | 7.01±1.36 | 0.550 |
| ESR (mm/1 h) | 53.22±30.93 | 63.54±30.05 | 43.78±30.56 | 0.136 |
| CRP (mg/L) | 5.94±3.51 | 5.10±2.89 | 5.89±5.15 | 0.619 |
| Urinary protein (g/24 h) | 5.82±4.34 | 6.88±5.13 | 5.94±3.98 | 0.884 |
| Total CHO (mM/L) | 5.01±1.98 | 5.12±2.10 | 4.92±1.34 | 0.702 |
| TG (mmol/L) | 2.16±1.48 | 1.78±0.97 | 2.51±1.90 | 0.261 |
| HDL (mmol/L) | 0.89±0.42 | 1.11±0.50 | 0.84±0.43 | 0.432 |
| LDL (mmol/L) | 2.64±1.93 | 2.99±1.51 | 3.26±1.13 | 0.872 |
FPG – fasting plasma glucose; HbA1C – glycated hemoglobin; ESR – erythrocytes sedimentation rate; CRP – C-reactive protein; CHO – cholesterol; TG – triglycerides; HDL – high-density lipoproteins; LDL – low-density lipoproteins. Variables are represented as mean ±SD. The Mann–Whitney U test was used for statistical analysis. A p<0.05 was considered significant.
*
Significantly higher among diabetic nephropathy patients without diabetic retinopathy.